Acquisitions (Tables)

9 Months Ended

Sep. 30, 2023

Business Acquisition [Line Items]

Schedule of Consideration Transferred and the Respective Reporting Segment for Each Acquisition

In the nine months ended September 30, 2023, the Company acquired various other businesses which were accounted for under the acquisition method that complemented the Company’s existing product offerings. The following table reflects the consideration transferred and the respective reporting segment for the acquisitions (in millions):

Name of Acquisition	Date Acquired	Segment	Total Consideration		Cash Consideration		Goodwill
Acquifer Imaging GmbH and Deltabyte GmbH	January 4, 2023	BSI NANO	$	7.6	$	7.6	$	4.5
Pinpoint Testing LLC	March 28, 2023	BSI CALID		8.6		3.6		4.8
Fasmatech Science SA	March 3, 2023	BSI CALID		10.3		8.4		8.0
Interherence GmbH	July 3, 2023	BSI CALID		17.3		3.9		12.8
			$	43.8	$	23.5	$	30.1

In the nine months ended September 30, 2023, the Company also made several strategic investments. The following table reflects the consideration transferred and the respective reporting segment for the investments (in millions):

Name	Financial Statement Classification	Date Acquired	Segment	Total Consideration		Cash Consideration
Tome Biosciences	Other long-term assets	July 26, 2023	Corporate	$	10.0	$	10.0
Other Investments	Other long-term assets	Various	Various		9.2		9.2
				$	19.2	$	19.2

Biognosys Ag [Member]

Business Acquisition [Line Items]

Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions

The components and fair value allocation of the consideration transferred in connection with the acquisition are as follows (in millions):

Consideration Transferred:
Cash paid	$	73.6
Cash acquired		(9.5	)
Holdback		0.2
Fair value of redeemable noncontrolling interest		2.5
Total consideration transferred	$	66.8
Allocation of Consideration Transferred:
Accounts receivable	$	3.6
Inventories		0.4
Other current assets		0.9
Property, plant and equipment		8.0
Other assets		4.3
Intangible assets:
Technology		10.2
Customer relationships		13.8
Trade name		2.7
Backlog		0.8
Goodwill		47.5
Liabilities assumed (a)		(25.4	)
Total consideration allocated	$	66.8

(a) This amount includes assumed liability for vested employee awards of $6.3 million on acquisition date and was settled in the post-closing period ended March 31, 2023.

Zontal Inc [Member]

Business Acquisition [Line Items]

Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions

The components and fair value allocation of the consideration transferred in connection with the acquisition are as follows (in millions):

Consideration Transferred:
Cash paid	$	14.8
Cash acquired		(0.2	)
Fair value of contingent consideration		0.5
Fair value of hybrid liability		18.5
Total consideration transferred	$	33.6
Allocation of Consideration Transferred:
Accounts receivable	$	0.7
Other current assets		0.3
Other assets		1.2
Intangible assets:
Technology		5.8
Customer relationships		4.0
Trade name		1.1
Backlog		0.2
Goodwill		27.4
Liabilities assumed		(7.1	)
Total consideration allocated	$	33.6